AbbVie Drops Legal Action In EU Drug Secrecy Case

Published: Apr 04, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - AbbVie, one of the two U.S. companies trying to stop Europe's drugs regulator from releasing previously secret clinical trials data, said on Thursday it had withdrawn lawsuits against the watchdog.

The decision follows a move by the London-based European Medicines Agency (EMA) to accept a new set of redacted documents submitted by AbbVie, along with the company's rationale for removing certain commercially confidential information.

Help employers find you! Check out all the jobs and post your resume.

Back to news